VanEck Pharmaceutical ETF Rating $89.52 +1.09 (+1.23%) Closing price 03:59 PM EasternExtended Trading$89.38 -0.13 (-0.15%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.76Holdings in PPH have an aggregate rating of Moderate Buy based on 250 analyst ratings issued in the past year covering 21 companies (90.1% of the portfolio).PPH Aggregate Price Target$89.52High Prediction$89.52Average Prediction$89.52Low Prediction$89.52Holdings in PPH have an aggregate price target of $89.52 and a range of $89.52 to $89.52 covering 21 companies (90.1% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.09%LLYEli Lilly and Company$823.59+2.4%4.9876 of 5 stars2.81$997.22 21.1%21Upcoming EarningsAnalyst ForecastShort Interest ↑Analyst RevisionPositive News7.12%JNJJohnson & Johnson$152.78+1.1%4.969 of 5 stars2.56$170.44 11.6%18Analyst ForecastShort Interest ↓Analyst Revision6.62%ABBVAbbVie$175.54+0.2%4.9773 of 5 stars2.88$205.00 16.8%24Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News6.44%NVONovo Nordisk A/S$85.33+1.5%4.8893 of 5 stars3.00$145.25 70.2%7News Coverage5.43%MRKMerck & Co., Inc.$98.91+0.6%4.9842 of 5 stars2.67$122.67 24.0%21Upcoming EarningsDividend AnnouncementAnalyst ForecastBuyback AnnouncementAnalyst RevisionPositive News5.15%AZNAstraZeneca$71.24+1.4%3.917 of 5 stars3.00$89.75 26.0%9Upcoming EarningsShort Interest ↑4.94%SNYSanofi$54.15+3.8%3.5985 of 5 stars3.00$60.00 10.8%3Earnings ReportAnalyst UpgradeOptions VolumeAnalyst RevisionNews CoverageGap Up4.90%PFEPfizer$26.89+1.0%4.9883 of 5 stars2.50$31.92 18.7%16Upcoming EarningsAnalyst ForecastShort Interest ↑4.85%CORCencora$258.54+1.0%4.6268 of 5 stars2.82$278.40 7.7%11Upcoming EarningsAnalyst ForecastShort Interest ↓News CoveragePositive News4.82%MCKMcKesson$605.16+0.3%4.7998 of 5 stars2.94$646.14 6.8%16Upcoming EarningsDividend AnnouncementNews CoveragePositive News4.65%BMYBristol-Myers Squibb$59.11+0.1%4.8364 of 5 stars2.29$56.60 -4.2%21Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News4.53%GSKGSK$35.35+0.8%2.9175 of 5 stars2.67$43.25 22.3%9Upcoming Earnings4.46%ZTSZoetis$172.61+1.4%4.878 of 5 stars3.08$215.00 24.6%12Analyst ForecastNews CoveragePositive News4.39%HLNHaleon$9.57+0.4%3.2101 of 5 stars2.71$10.95 14.5%7Short Interest ↑4.19%TEVATeva Pharmaceutical Industries$17.88-3.6%3.6246 of 5 stars2.75$22.00 23.1%8Earnings ReportAnalyst ForecastOptions VolumeNews CoverageHigh Trading Volume1.73%VTRSViatris$11.42+0.8%3.3235 of 5 stars2.00$13.67 19.7%3Positive News0.99%JAZZJazz Pharmaceuticals$125.05+0.6%4.9594 of 5 stars2.87$177.00 41.5%15Short Interest ↓Analyst RevisionPositive News0.56%ELANElanco Animal Health$12.47+1.4%4.2563 of 5 stars2.25$16.29 30.7%8Analyst Forecast0.54%OGNOrganon & Co.$15.97+0.8%4.8989 of 5 stars2.40$21.33 33.6%50.38%PRGOPerrigo$24.90+0.9%4.9415 of 5 stars2.40$35.00 40.6%5Short Interest ↑0.30%PDCOPatterson Companies$30.99+0.1%4.2996 of 5 stars2.09$26.57 -14.3%11Analyst ForecastNews CoveragePositive News This page (NASDAQ:PPH) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
